![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » FDA Clears Lorals for Protection Underwear Against STIs
FDA Clears Lorals for Protection Underwear Against STIs
May 16, 2022
The FDA has granted 510(k) clearance to Lorals for Protection, ultra-thin latex panties that are intended to protect against sexually transmitted infections (STIs).
Los Angeles, Calif.-based Lorals says the vanilla-flavored latex, which is as thin as a condom, provides wearable STI protection for safer oral sex.
The FDA has placed the underwear into its medium-risk regulatory category, Class II (Special Controls). The single-use underwear undergoes testing to ensure it meets the FDA’s standards for STI protection during oral-vaginal and oral-anal sex, the company said.
Upcoming Events
-
21Oct